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Abstract 13 
Microvesicles (MVs) generated and released by astrocytes, the brain prevalent cells, crucially 14 
contribute to intercellular communication, representing key vectorized systems able to spread 15 
and actively transfer signaling molecules from astrocytes to neurons, ultimately modulating 16 
target cell functions. The increasing clinical relevance of these signaling systems requires a 17 
deeper understanding of MV features, currently limited by both their nanoscale dimensions and 18 
the low rate of their constituent release. Hence, to investigate the features of such glial signals, 19 
nanotechnology-based approaches and the applications of unconventional, cost-effective tools in 20 









MVs shedding from astrocytes in cultures and s-GO generated MVs are compared with those 22 
generated by a natural stimulant, namely ATP, by atomic force microscopy, light scattering, 23 
attenuated total reflection–fourier transform infra-red and ultraviolet resonance Raman 24 
spectroscopy. We also report the ability of both types of MVs, upon acute and transient exposure 25 
of patch clamped cultured neurons, to modulate basal synaptic transmission, inducing a stable 26 
increase in synaptic activity accompanied by changes in neuronal plasma membrane elastic 27 
features. 28 
 29 
Keywords: graphene oxide, extracellular vesicles, atomic fore microscopy and spectroscopy, 30 
FTIR-ATR and UVRR spectroscopy, synaptic activity, cortical neuronal cultures 31 
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1. Introduction 33 
In biology, newly described forms of intercellular communication comprise the release of 34 
vesicles, named extracellular vesicles, from virtually ll cell types, including resident glial cells 35 
of the central nervous system (CNS), such as astrocytes and microglia.[1,2] In particular, the 36 
shedding of membrane vesicles is a recognized form f cross talk in the multidimensional 37 
signaling between astrocytes, (i.e. the majority of cells in the mammalian CNS), and neurons in 38 
physiology, but also in neurodegenerative and neuroinflammatory diseases as well as in brain 39 
tumors. Extracellular vesicle signaling molecules, either stored within their cargo or embedded in 40 
their plasma membrane, modulate relevant processes in the development, physiology and 41 
pathology of CNS target cells.[3–6] The signaling system based on release of extracellular 42 
vesicles comprises shedding microvesicles (MVs) and exosomes, characterized by different size, 43 









MVs are nanovesicles able to interact specifically with cells at local or distant sites.[9] In 45 
maintaining CNS functions, glial cells intensely communicate with neurons, also via the release 46 
of MVs, which represents a highly versatile tool to functionally impact the CNS.[10–12] MVs 47 
are considered a “vectorized” signaling system able to bind their target cells to transmit specific 48 
information. The reported spreading ability of MVs has suggested their potential exploitation as 49 
biomarkers or as engineered therapeutic carriers.[13] A comprehensive correlation between 50 
conditions used to release and harvest MVs from the same cell type, i.e. astrocytes, and their 51 
signaling ability, will impact our understanding of MVs physiology and the design of MV-based 52 
biomedical applications in the CNS.[14,15] Particular attention has to be conveyed to devise 53 
novel, cost-effective ways in generating MVs, in particular enhancing constitutive release.  54 
Here, we concentrate on graphene oxide (GO), the most c mmon derivative of graphene, 55 
whose properties can be tailored to adapt to new physical and biological applications.[16,17] GO 56 
flakes have been successfully designed for drug delivery applications in biomedicine.[18] In the 57 
CNS, small GO nano-flakes (s-GO) were shown to induce constitutive MV release from cultured 58 
astrocytes and to potentiate evoked MV release induce  upon exposure to bzATP.[19]  s-GO 59 
flakes, due to their physical features at the nanoscale, were reported to interfere with cellular 60 
membrane dynamics.[19,20] In addition, via adhesion to the plasma membrane, s-GO may alter 61 
the  mechanical features of the lipid bilayer[21] triggering genuine biological responses, such as 62 
MVs signaling. Thus s-GOs may represent a tool to exploit mechanical signaling at the 63 
nanoscale to activate membrane release of MVs. Drug delivery applications where vesicle 64 
release from genetically engineered cells is requird, may take advantage of the mechanical 65 
modulation of vesicle release brought about by graphene-based nanomaterials, representing a 66 









to induce MVs release, such as ATP, could in fact negatively affect cell physiology by 68 
promoting astrogliosis and inducing microglia-mediated neuroinflammatory responses.[22] 69 
We use the ability of s-GO to substantially increase the production of MVs from astrocytes to 70 
provide, for the first time, a robust and comparative vesicle characterization by means of ultra-71 
microscopy, attenuated total reflection–fourier transform infra-red (FTIR-ATR) and UV 72 
Resonant Raman (UVRR) spectroscopy. We additionally explore by single cell patch-clamp 73 
recordings the impact of acute, local and transient delivery of MVs on neuronal basal synaptic 74 
activity and by atomic force microscopy (AFM) the accompanying changes in neuronal plasma 75 
membrane elastic features. 76 
2. Material and Methods 77 
2.1 Graphene oxide nanosheets synthesis  78 
GO was manufactured under endotoxin-free conditions through our modified Hummers’ method 79 
as previously described.[19] The complete characterization of the material used is shown and 80 
summarised in the Supplementary experimental section and Supplementary Figure S1 and Table 81 
S1. 82 
2.2 Cell Cultures  83 
All experiments were performed in accordance with the EU guidelines (Directive 2010/63/EU) 84 
and Italian law (decree 26/14) and were approved by the local authority veterinary service and by 85 
our institution (SISSA-ISAS) ethical committee. All efforts were made to minimize animal 86 
suffering and to reduce the number of animals used. Animal use was approved by the Italian 87 
Ministry of Health, in agreement with the EU Recommendation 2007/526/EC. 88 
Primary glial cultures were obtained from cortices isolated from neonatal rats (Wistar) at 89 









plastic 150 cm2 flasks and incubated at 37 °C; 5 % CO2 in culture medium composed of DMEM 91 
(Invitrogen), supplemented with 10 % fetal bovine serum (FBS; Thermo Fisher), 100 IU/ mL 92 
penicillin, and 10 mg/mL streptomycin.  93 
Cortical neurons were isolated from neonatal rat cortices (Wistar) at postnatal day 0-1 94 
(P0−P1). Dissociated cells were then plated on poly-L-ornithine (Sigma) coated coverslips 95 
(Kindler, EU) at a concentration of 150000 cells in a volume of 200 μL and incubated at 37 °C; 5 96 
% CO2 in a culture medium composed of Neurobasal-A (Thermo Fischer) containing 2% B27 97 
(Gibco), 10 mM Glutamax and 0.5 μM Gentamycin (Gibco) for 8-10 days in vitro (DIV) before 98 
performing electrophysiological experiments. 99 
2.3 MV Isolation 100 
 MV shedding and isolation was performed as previously described.[19] One pool of MVs 101 
were collected from 21-24 DIV glial cultures previously treated with graphene oxide nanoflakes 102 
(s-GO) (10 µg/mL[19]), added to culture medium once and left for 6 days. At the end of 6-days 103 
exposure, the medium was removed and substituted with physiological saline solution, with the 104 
following composition: 152 mM NaCl, 4 mM KCl, 1 mM gCl2, 2 mM CaCl2, 10 mM HEPES 105 
and 10 mM Glucose (pH adjusted to 7.4), at 37 °C and 5 % CO2 for 60 min prior to MVs 106 
collection and purification. The MVs pool was isolated from cultures treated (30 min) with 107 
benzoyl-ATP (bzATP; 100 μM) diluted in physiological saline solution. The 6-days exposure 108 
timepoint was chosen on the basis of previous western blot experiments, and confirmed by our 109 
current experiments testing MVs release after 3 days of s-GO exposure (supplementary Figure 110 
S2).[19] Negative controls were incubated with physiological solution without the presence of 111 
bzATP or s-GO. After the incubation period, cell medium was collected and centrifuged for 15 112 









MVs were pelleted by centrifugation at 20000 × g for 2 hours. For Ca2+ deprivation experiments, 114 
prior to supernatant collection and MVs pellet centrifugation, cultures were pre-incubated for 45 115 
min in a saline solution identical to the physiological saline solution except for 0 mM CaCl2, 3 116 
mM MgCl2 and 1mM EGTA to allow the depletion of intracellular calcium storage. Upon this 117 
pre-treatment, we harvest the MVs from controls, s-GO treated and bzATP (30 min in Ca2+ 118 
deprived solution; supplementary Figure S3). 119 
2.4 Western blot analysis 120 
MVs were prepared as previously reported, briefly they were re-suspended in lysis buffer (50 121 
mM Tris-HCl, pH 8.0, 150 mM NaCl, 1 % NP40, 0.1 % SDS), sonicated for 30 s, and then 122 
boiled at 95 °C for 5 min.[19] Samples were run on a 10 % polyacrylamide gel and blotted onto 123 
nitrocellulose membranes (Millipore, Italy). Membranes were then blocked in PBS-Tween-20 124 
(0.1 %) plus 5 % nonfat dry milk and incubated with the primary antibody antiflotillin-1 (dilution 125 
1:1000) for 16 h at 4 °C. Membranes were then washed with PBS-Tween and incubated with 126 
peroxidase-conjugated anti-mouse secondary antibody ( ilution 1:1000). Detection of 127 
immunolabeled ECL-exposed protein bands was measured with UVI-1D software over three 128 
independent experiments. 129 
2.5 Immunofluorescence and confocal microscopy 130 
Primary glial and cortical neurons cultures were fixed in 4 % formaldehyde (PFA, prepared 131 
from fresh paraformaldehyde) in PBS for 20 min at room temperature (RT) and then washed in 132 
PBS. Free aldehyde groups were quenched in 0.1 M glycine solution for 5 min. The samples 133 
were permeabilized in 5 % fetal bovine serum (FBS), 0.3 % Triton-X 100 in phosphate buffer 134 
solution (PBS) for 30 min at RT. Samples were then incubated with primary antibodies (mouse 135 









Aldrich, 1:500 dilution) diluted in PBS with 5 % FBS at 4 °C for 1 hours. Samples were then 137 
incubated with secondary antibodies (Alexa 488 goat anti-mouse, Invitrogen, 1:500 dilution; 138 
Alexa 594 goat anti-rabbit, Invitrogen, 1:500 dilution), and DAPI (Invitrogen, dilution 1:200) to 139 
stain the nuclei, for 45 min at RT and finally mounted on 1 mm thick glass coverslips using 140 
Fluoromount mounting medium (Sigma-Andrich). Images were acquired using a Nikon C2 141 
Confocal, equipped with Ar/Kr, He/Ne and UV lasers with a 40 × or 60 × (1.4 NA) oil-objective 142 
(using oil mounting medium, 1.515 refractive index) to acquire glial cultures images and cortical 143 
neurons images respectively. 200 × 200 µm fields were acquired for cortical neurons images and 144 
300 × 300 µm fields were acquired for glial cells images. Confocal sections were acquired every 145 
0.25 µm for both the cultures. 146 
2.6 Glial cell viability assay  147 
Primary rat astrocytes (21-24 DIV) were exposed to s-GO 10 μg/mL or to equivalent volumes 148 
of the vehicle for 6 days. Cells were stained with propidium iodide (PI, 1 µg/ml; 15 min) for cell 149 
death quantification and subsequently fixed in PFA and labelled for DAPI for nuclei 150 
visualization and GFAP for visualizing astrocytes. The red (PI positive) fluorescent nuclei 151 
indicating dead cells were quantified at 40 × (1.4 NA) magnification using a Nikon C2 Confocal 152 
microscope, equipped with Ar/Kr, He/Ne and UV lasers, with random sampling of 10 fields per 153 
sample (n = 3 coverslips/sample, from 3 independent culture preparations).  The average 154 
percentage of dead cells was calculated counting visual fields selected. 155 
2.7 FM1-43 staining 156 
Glial cells were incubated with the fluorescent styryl dye FM1-43 (2 μM) for 2 min in order to 157 
completely stain plasma membrane, then extensively washed with PBS and exposed for 30 min 158 









chamber mounted on an inverted microscope (Nikon Eclipse Ti-U) and observed with a 40 × 160 
objective (0.6 NA, PlanFluor, Nikon). Images (512 × 512 px) were acquired for 10 min with an 161 
exposure time of 150 ms (6.6 Hz) by a Hamamatsu Orca-Flash 4.0 digital camera controlled by 162 
an integrating imaging software package (HCImage, Hamamatsu). Recorded images were 163 
analyzed offline with the Clampfit software (pClamp suite, 10.2 version; Axon Instruments). 164 
Image time stacks were analyzed in selected regions of interest (ROI) to measure the 165 
variations in FM1-43 fluorescence intensity over time. Natural sample bleaching over time, 166 
due to prolonged light exposure, has the same time-course and intensity in all the three 167 
groups, as previously described[19]. 168 
2.8 Atomic Force Microscopy Analysis 169 
AFM characterization was performed as previously described.[19] Briefly, the pellet of MVs 170 
was re-suspended in PBS solution after isolation frm cell cultures and a 15 μL drop of sample 171 
solution was placed and left to adsorb (30 min) onto a freshly peeled mica substrate. Vesicles 172 
were then fixed with 1% formaldehyde for 1 h (RT) in order to prevent their collapse during 173 
AFM acquisition. MVs were then washed with PBS and dried under a gentle stream of nitrogen. 174 
AFM analysis was performed in air at RT, using the semicontact mode of a commercial 175 
instrument (Solver Pro, NT-MDT, RU). Silicon tips (NSC36/CR-AU, MikroMash, USA) with a 176 
typical force constant of 0.6 nN/nm and a resonance frequency of about 65 kHz were employed. 177 
Topographic height and phase images were recorded at 512 × 512 pixels at a scan rate of 0.5 Hz. 178 
Image processing was performed using Gwyddion freewar  AFM analysis software, version 179 
2.40. Diameter and height of each vesicle were evaluated from cross-line profiles, and results 180 
were statistically analyzed using Prism (Graphpad software). 181 









9-10 DIV cortical neurons were exposed to MVs obtained by glial cultures treated with bzATP 183 
or s-GO and neuronal rigidity was assessed with AFM, 24 hours after MVs exposure. Force 184 
spectroscopy measurements were performed with a commercial Smena AFM (NT-MDT, RU) 185 
mounted on an inverted microscope (Nikon Eclipse Ti-U). AFM cantilever deflection was 186 
measured when pushed against cortical neurons plated on a glass coverslip. Deflection values 187 
were subsequently converted into a force versus indentation curve based on cantilever spring 188 
constant and its displacement. Neuronal rigidity was evaluated in 50 randomly chosen neurons 189 
for each condition (from 3 independent experiments), acquiring three force spectroscopy curves 190 
in the center of each cell soma. The AFM tip was poitioned by using an inverted microscope in 191 
bright field mode.  192 
AFM micro-cantilevers with an elastic constant of about 0.03 nN/nm and a resonance 193 
frequency of about 10 kHz (CSG01 tipless cantilevers from NT-MDT, RU) were used. A 194 
borosilicate glass microsphere of about 18 μm in diameter (18.2 ± 1.0 mm from Duke Standards, 195 
CA, USA) was manually glued at the end of each cantilevers using a UV curable glue (Norland 196 
Optical Adhesive 61 from Norland Products Inc., NJ,USA). Force spectroscopy measurements 197 
were performed at a constant indentation speed of 1 mm/s with a maximum value of indentation 198 
deepness set at 500 nm. Elastic modulus values (E), expressed in kPa, were determined by fitting 199 
obtained force–indentation curves with a Hertzian model for the tip, using AtomicJ (v. 1.7.3) 200 
analysis software.[24] 201 
2.10 Nanoparticle Tracking analysis (NTA) 202 
Measurement and analysis of MVs size distribution by NTA was performed on a NanoSight 203 
LM10 system (Malvern) using approximately 500 μL of MVs of both conditions (bzATP-204 









(recorded at 25 FPS; 3 videos per group) for each sample were acquired at RT using the 206 
maximum camera gain, a detector threshold equal to 8 and analyzed by the NanoSight particle 207 
tracking software to calculate size and vesicle concentration. 208 
2.11 FTIR-ATR Spectroscopy and UV Resonant Raman (UVRR) Measurements 209 
MVs were isolated from 21-24 DIV glial cultures by centrifugation as described above. MVs 210 
pellet was successively washed with NaCl solution (150 mM) and finally re-suspended in 50 μL211 
of the same solution in order to avoid contribution f phosphate and sugar groups to the IR 212 
absorbance spectra. The IR measurements were carried out at the BL10.2-IUVS beamline at 213 
Elettra synchrotron Trieste. The spectra were colleted in ATR mode using a MIR DLaTGS 214 
detector and a KBr-broadband beam-splitter. For each IR measurement, 2 μL of sample solution 215 
were spread over the whole area of a monolithic diamond ATR plate and left to dry forming a 216 
thin film. For each sample, 20 spectra were collected in the range 4000-800 cm-1, accumulating 217 
256 scans for each spectrum reaching a resolution of 4 cm-1. Each spectrum was corrected for the 218 
background, aqueous vapor, CO2 and not normalized to any absorbance band.   219 
UVRR measurements were performed at the BL10.2-IUVS beamline at Elettra synchrotron 220 
Trieste using the experimental set-up reported.[25]  5 μL of vesicles  solution were drop-casted 221 
onto an aluminum foil, allowed to dry and kept under nitrogen purging. All the measurements 222 
were performed at RT, using an excitation wavelength of 244 nm and tuning the power of the 223 
incoming radiation to 50 µW. The outcoming radiation was collected in backscattering geometry 224 
by using a triple stage spectrometer (Trivista, Princeton Instrument) with a spectral resolution of 225 
8 cm-1. Samples were continuously oscillated horizontally in order to avoid photodamaging.  226 









Patch-clamp recordings (whole-cell, voltage clamp mode) were performed from visually 228 
identified (under differential interference contras - DIC - microscopy) cortical neurons (DIV 8-229 
10) placed in a recording chamber, mounted on an inverted microscope (Eclipse Ti-U, Nikon, 230 
Japan) and superfused with control physiological saline solution of the following composition (in 231 
mM): 152 NaCl, 4 KCl, 1 MgCl2, 2 CaCl2, 10 HEPES and 10 Glucose (pH adjusted to 7.4 by 232 
NaOH 1M; osmolarity 300 mOsm). Cells were patched with glass pipettes (4-7 MΩ) containing 233 
(in mM): 120 K gluconate, 20 KCl, 10 HEPES, 10 EGTA, 2 MgCl2 and 2 Na2ATP (pH adjusted 234 
to 7.35 by KOH; osmolarity 298 mOsm). All electrophysiological recordings were performed at 235 
RT and the spontaneous, basal synaptic activity was recorded by clamping the membrane voltage 236 
at –70 mV (corrected for liquid junction potential, which was –14 mV). To investigate the acute 237 
effect on synaptic activity of glia-derived MVs, aninjection pipette (patch pipette with resistance 238 
of 1–4 MΩ) filled with MVs previously isolated glial cultures as described above and re-239 
suspended in 100 μL of extracellular saline solution was positioned at 200 μm from the cell soma 240 
and connected to a pico-spritzer (PDES-02DX, npi Electronics) with 0.3 psi in-line pressure.[19] 241 
On the basis of MVs quantification obtained by NTA measurements, and considering that MVs 242 
isolation was performed using the same protocol in all the experiments described, we calculated 243 
that the concentration of MVs used for these tests wa approximately of 6.64 × 109 for MVs 244 
obtained by bzATP stimulation and 1.64 × 1010 for MVs isolated from s-GO treated cultures. 245 
Baseline spontaneous synaptic activity was recorded for the 10 min prior delivering the puff 246 
(500 ms duration) of MVs and followed up for 20 min to verify changes in post synaptic current 247 
(PSC) frequency and amplitude induced by the fusion of MVs with neuronal membranes.  248 
Data were collected by Multiclamp 700B patch amplifier (Axon CNS, Molecular Devices) and 249 









recorded events were analyzed offline with the AxoGraph 1.4.4 (Axon Instrument) event 251 
detection software (Axon CNS, Molecular Devices). 252 
2.13 Statistical Analysis 253 
Data sets found to follow a non-normal distribution, were represented as box plot. The central 254 
thick horizontal bar in the box plots indicates them dian value, while the boxed area extends 255 
from the 25th to 75th percentiles with the whiskers ranging from the 2.5th to the 97.5th percentiles. 256 
Statistically significant differences between two nn-parametric data sets were assessed by 257 
Mann-Whitney’s test, while to assess statistically significant differences among three data-set we 258 
used the Kruskal-Wallis test and Dunn’s post hoc test. P < 0.05 was considered at a statistically 259 
significant.  260 
 261 
3. Results and discussion 262 
Astrocytes were isolated from postnatal (2-3 days) rat (Wistar) cortices, as previously 263 
described.[19,20,23] We used visually homogenous s-GO dispersions containi g s-GO 264 
nanosheets with lateral dimensions predominantly betwe n 50 – 500 nm.[19,20] We treated pure 265 
glial cell cultures with s-GO (10 μg/mL) for 6 days.[19] Immunofluorescence labeling by antigen 266 
against glial-fibrillary acidic protein (GFAP), an i termediate filament protein that is highly 267 
specific for cells of the astroglial lineage, was ued to visualize control and s-GO-treated 268 
neuroglial cultures (GFAP, in green; Fig. 1a).[26] At the low concentrations used, s-GO 269 
treatment did not impair astrocyte morphology and cell density when compared with matched 270 
control cultures (box-plot in Fig. 1b).[19,27] Viability of glial cells was confirmed by propidium 271 
iodide (PI) cell death assay. Control and s-GO treated cultures were incubated with PI, which 272 









(bar plot in Fig. 1d). Graphene nanosheets cytotoxicity s a largely debated issue, due to the 274 
variable impact on cell toxicity of several material’s features, related either on the GO physical-275 
chemical properties (thickness, size, surface functio alization, aggregation state and 276 
concentration) or on the synthesis method[28,29], the experimental conditions adopted here and 277 
in our previous works[19,20] exclude any cytotoxic effect on glial cells or neurons, both in vitro 278 
and in vivo.  279 
MVs are released into the extracellular space by direct budding from the plasma membrane of 280 
astrocytes.[30] To explore the dynamics of MVs release in control, in s-GO treated and in ATP 281 
treated (see below) astrocytes, we measured the pres nc  of changes in membrane trafficking by 282 
briefly incubating cultures with the fluorescent styryl dye FM1-43 and then quantifying the 283 
astrocyte-membrane fluorescence decay to provide a cumulative measure of exocytosis in the 284 
different growth conditions.[19,30] 285 
FM dyes are fluorescent probes that reversibly stain membranes, and are largely used for 286 
optical real-time measurements of membrane dynamics and secretory processes.[31–33] 287 
Incubation with the FM dye (2 μM, 2 min) resulted in clear surface membrane staining of 288 
control, bzATP, an agent known to evoke massive MVs release (100 μM, 30 min) and s-GO 289 
treated cultures (10 μg/mL, 6 days), highlighted in Figure 1e (left panels).[30] Brighter spots 290 
were considered as adherent debris and were excluded from the analysis. Besides these, both 291 
bright and weak FM-stained plasma membrane domains were present along the whole 292 
cytoplasmic surface and became visible within 2 min incubation (Fig. 1e). Due to this initial 293 
variability in the intensity of the membrane staining, all FM de-staining measures were 294 
normalized to the relative time 0. Once astrocyte membranes were labeled by the fluorescent dye 295 









s-GO treated cultures, or during acute exposure to bzATP, under the same culturing 297 
conditions.[19] Representative fluorescence intensity traces are shown in Figure 1f (top plot); the 298 
dynamic of the fluorescence decay observed in control cultures, indicates the presence of 299 
physiological bleaching of fluorophore over the acquisition time course, however  s-GO and 300 
bzATP groups, despite the same bleaching-induced loss of fluorescence, showed a faster de-301 
staining rate in respect to controls. This is also visualized by the time-lapse images framed at 302 
time 0 s, 300 s and 600 s of the crude recordings (Figure 1e middle and right panels). We 303 
quantified the fluorescence decay time constant (τ) values (box plot of Figure 1f) and detected 304 
shorter decay values in both bzATP and s-GO groups (mediancontrol= 219 s; medianbzATP= 184.2 305 
s; medians-GO= 163.9 s). This result suggested that the membrane de-staining was actually related 306 
to MVs release, as expected in bzATP treated cells, more than to other membrane turnover 307 
activities. Such a release was comparable between bzATP and s-GO, both significantly faster 308 


















Fig. 1. Graphene oxide nanosheets does not affect astrocytes vitality. Cultured astrocytes release microvesicles 311 
(MVs) upon ATP or s-GO stimulation. a) Confocal images visualize cultured astrocytes in cotrol and after s-GO 312 
(10 μg/mL; 6 days) treatment; anti-GFAP, in green, and DAPI (to visualize nuclei), in blue; scale bar 50 μm. b) Box 313 
plot summarizes the cell density measures; note the similar values in both groups. c) Confocal images visualize 314 
cultured astrocytes in control and after s-GO (10 μg/mL; 6 days) treatment. Cultures were treated with propidium 315 
iodide (PI) to visualize death cells. Anti-GFAP, in green,  DAPI (to visualize nuclei), in blue and PI in red; scale bar 316 
50 μm. d) Histogram summarizes the percentage of death cells followed the s-GO exposure and in control condition; 317 
note that there are no significant difference betwen two groups  e) Surface membrane staining and activity 318 
dependent de-staining of FM1-43 in cultured astrocytes, scale bar 25 μm. f) Normalized FM1-43 de-staining traces 319 
(top) in control astrocytes (light grey), in bzATP treated once (orange) and in s-GO treated once (black). The box 320 
plot (bottom) summarizes the decay time constant τ of FM1-43 de-staining in the three conditions (mediancontrol = 321 
219.2 s; medianbzATP = 184.2 s; medians-GO = 163.9 s). Thick horizontal bars in the box plots indicate median value; 322 
boxed area extends from the 25th to 75th percentiles, whiskers from 2.5th to the 97.5th percentiles. Significance: **P < 323 
0.01 ***P < 0.001, Kruskal-Wallis test, Dunn’s post hoc test).  324 
 325 
 The release of MVs suggested by FM1-43 measures, wa  confirmed by immunoblot analysis 326 
for the biomarker flotillin-1 of the supernatant collected from control and treated cultures (Fig. 327 
2a). As expected, bzATP stimulation and s-GO incubation induced the appearance of a thick 328 
band corresponding to flotillin-1 (Figure 2a), a signature of MVs release by astrocytes, with an 329 
additive effect between s-GO exposure and pharmacological stimulation with bzATP (s-GORinger 330 
is quantified as 100 % more than ControlRinger; bzATPRinger is quantified as 360 % more than 331 
ControlRinger; bzATPs-GO is quantified as 2900 % more than ControlRinger. Calculated over three 332 
independent experiments).[19,30,34] In control conditions only a weak band was perceived, 333 
indicating that MVs constitutive release in culture was poorly detectable. Atomic force 334 
microscopy (AFM) topographic reconstruction of re-suspended MVs pellet (Fig. 2b) confirmed 335 
the presence of MVs detected by the immunoblot in both bzATP (mvA) and s-GO (mvG) 336 
groups. When investigating the effect of shorter (3 days) exposure to s-GO, western blot 337 
experiments (supplementary Fig. S2) showed the absence of a significant increase in MVs 338 









days s-GO (supplementary Fig. S2) suggesting that s-GO already modulated MVs release, but 340 
longer time of s-GO exposure are needed to enhance basal release in the absence of additional 341 
stimuli. In an additional set of western blot experiments, we tested the sensitivity of bzATP and 342 
s-GO MVs release to extracellular calcium deprivation (supplementary Fig. S3). Differently 343 
from bzATP, s-GO release was apparently not affected by calcium removal. In control condition, 344 
a thick band appeared upon calcium removal, suggestive of an increase in constitutive release 345 
(supplementary Fig. S3). These preliminary results hint at release mechanisms differently tuned 346 
by calcium among control, bzATP and s-GO and requir f ther studies.  347 
We systematically investigated and compared the MV size distribution by means of AFM and 348 
nanoparticle tracking analysis (NTA) measurements. AFM images show the presence of 349 
roundish protrusions of dimensions compatible with the size of MVs. No other kind of 350 
contaminant was present, to indicate that the procedure for isolating and collecting MVs from the 351 
medium was clean and effective.  When analyzed by AFM (Fig. 2c) s-GO-derived MVs (mvG) 352 
lateral size were significantly smaller (n = 72, medianmvG= 244 nm) than bzATP-derived ones 353 
(mvA; n = 107, medianmvA= 479 nm) (P < 0.001). Conversely, we detected no differences in MV 354 
height values (medianmvG= 19 nm; medianmvA= 22 nm; P = 0.17). Within each group, the 355 
distribution of size values detected was not negatively correlated to the height, as shown in 356 
Figure 2d (left; rmvG= 0.8808 and rmvA= 0.4039; P < 0.001). However, AFM experiments were 357 
performed in air, thus a not specific flattening of MVs caused by vesicle collapsing might have 358 
influenced these measurements. In principle differences in MV elastic properties, potentially 359 
related to diverse membrane components, might lead to a variable collapsing of MVs when 360 









Since AFM measurements are affected by the reduced siz  of the analyzed samples, and might 362 
not reflect the entire MVs population, we decided to use nanoparticle tracking analysis (NTA) to 363 
perform bulk analysis of vesicles in aqueous suspenion. NTA tracks single particle Brownian 364 
motion within a dark field microscope, derives mean square vesicles velocity and translates them 365 
into size distribution.[35] NTA revealed a more complex pattern of size distribu ion (Fig. 2e): in 366 
the case of mvA we observed three subpopulations of vesicles at 115 nm, 235 nm and 400 nm 367 
respectively while in the case of mvG we found two partially overlapping peaks at 135 nm and 368 
168 nm, plus two distinct peaks at 275 nm and 385 nm (Fig. 2e). The diameter analysis revealed 369 
a slight, but not significant, difference between the wo populations with the diameter of mvG 370 
smaller and less distributed, compared to those of mvA (medianmvA = 235.4 nm; medianmvG = 371 
183.6 nm) (Fig. 2f).  These results convincingly suggested a comparable size distribution in both 372 
MV populations and subpopulations. However, we detect d a significant difference in the 373 
number of vesicles released within the same time window (Fig. 2e) to indicate that cultures 374 
treated with s-GO produced more MVs when compared to cultures stimulated with bzATP (mvA 375 
=  ̴3.32 × 108 vesicle/mL; mvG =   ̴8.19 × 108 vesicles/mL), consistently with our results obtained 376 
by MV release analysis and immunoblot (but see also Vi novitz et al. 2019[36]). Therefore, even 377 
though the overall size of the MV population produced did not change, s-GO was more efficient 378 










Fig. 2. Graphene oxide nanosheets and bzATP induce MVs release in Astrocytes. Microvesicle released by glial 381 
cells via bzATP or s-GO stimulations characterized by ultra-resolution approaches. a) Western blotting of the pellets 382 
(top row) and cell lysates (bottom row) for the MV marker flotillin-1 (N=3). Pellets were obtained from the medium 383 









stimulated (bzATP) by 100 μM bzATP. s-GORinger is quantified as 100% more than ControlRinger; bzATPRinger is 385 
quantified as 360% more than ControlRinger; bzATPs-GO is quantified as 2900% more than ControlRinger. Calculated 386 
over three independent experiments. b) AFM topographic reconstruction of MVs isolated from cultured primary 387 
astrocytes treated with bzATP (100 μM) and s-GO (10 μg/mL) and performed in air (semi-contact mode). Scale b r 388 
500 nm. c) Lateral size values distribution and median values for both groups, note that mvG lateral size is 389 
significantly smaller than that of mvA (medianmvA = 479 nm; medianmvA = 244.1 nm; ***P > 0.001, Mann-Whitney 390 
test). d) AFM measures of lateral size are plotted against AFM measures of height of MVs isolated from glial cells 391 
treated by bzATP (100 μM; mvA; in orange) or by s-GO (10μg/mL; mvG; in black).  e) Size distribution of MVs 392 
isolated from glial cells treated by bzATP (100 μM; in orange) or by s-GO (10 μg/mL; in black) measured by 393 
nanoparticle tracking analysis (NTA). Values of thepeaks are expressed in nm. f) Lateral size values distribution 394 
and median values for both groups, obtained by NTA measurement. 395 
 396 
 397 
In order to analyze the macromolecular composition of MVs we took advantage of two 398 
complementary techniques: FTIR-ATR and UVRR spectros opy. For these measurements, MVs 399 
were isolated by differential centrifugation as described before (see Material and Methods). To 400 
avoid any spurious effect due to the absorption of phosphate groups from the buffer, we washed 401 
and re-suspended the MVs pellet with a NaCl solution (150 mM). The infrared (IR) absorbance 402 
spectra (Fig. 3a) revealed a clear contribution of the CH and the phosphate bands linked to DNA 403 
in both samples, mvA and mvG, as well as the lipid signatures at 2900-3000 cm-1, arisen from 404 
the CH2 and CH3 stretching mode. The amide I and amide II bands between 1500 and 1785 cm
-1, 405 
the two major protein bands in the IR spectrum, show more pronounced differences between the 406 
two populations of vesicles. The amide I band, which is primarily related to the C=O stretching 407 
in the peptide bonds and modulated by the proteins’ secondary structures, displayed similar 408 
shapes for mvA and mvG. The amide II band, primarily due to C-N stretching and N-H in plane 409 
bending vibrations, also reflecting the protein secondary structure, was instead clearly depleted 410 
in the case of mvG. To gain insights into the contribu ion of different protein secondary 411 









the amide I + amide II region (Fig. 3b) and used the position of the minima to guide a 413 
multicomponent gaussian fit of the bands in the region 1500 and 1785 cm-1. The % area 414 
contributions obtained by the fit are reported in Fig. 3c. The low-energy flank of amide I of both 415 
mvA and mvG is characterized by the presence of the 1610-1613 cm-1 vibrational peak which 416 
could be addressed to a mixed contribution arisen from β-sheets and side-chains vibrations. 417 
Additionally, the band at 1660 cm-1 might also be derived from the presence of RNA in the418 
vesicles.[37]  Noteworthy, the relative populations of the peaks at approximately 1645 cm-1, 419 
1660 cm-1 and 1678 cm-1 are inverted between mvA and mvG. According to the literature[37], 420 
the 1645 cm-1 peak (depleted in mvG) might be assigned to random structures and/or helices; the 421 
1660 cm-1 peak (depleted in mvA) to flexible helices (as 310 helices); the 1678 cm
-1 peak 422 
(depleted in mvG) to beta structures such as b-turns. The bands at 1632 cm-1 and at 1693 cm-1, 423 
both present in the mvG only, are ascribed to anti-parallel beta sheet, as found in aggregates in 424 
tissues.[37,38] We can conclude that mvGs contain proteins with perturbed secondary structure, 425 
characterized by beta structure-based aggregates and flexible helices. No significant variations in 426 
the DNA phosphate bands were measured as well as the nature or localization of the DNA 427 
signature detected. It is interesting to note that in previous measures the DNA delivered by EVs 428 
has been reported to be stocked either inside the vesicles or on their surface[39].  429 
UV Resonant Raman (UVRR) measurements taken using an excitation wavelength of 244 nm 430 
(see experimental section and supplementary Fig. S4) confirmed the amide I signal depression in 431 
mvG absorption spectrum. Due to an overlap between th  UVRR s-GO band, we could not 432 
confirm or discard the presence of s-GO inside the vesicles. Thus, we cannot exclude that the 433 
changes in protein native structure might be due to s-GO altering the MV 434 









absence of astrocytes cytotoxicity, even upon prolonged exposure to s-GO, together with the 436 
functional measures of increased MVs release kinetic obtained by live imaging, are against a 437 
mere alteration in protein integrity due to denaturtion of membrane proteins in the presence of 438 
s-GO.[40–42] FTIR-ATR spectroscopy is a powerful tool to assess the disordered character of 439 
proteins, and the absence of a well-defined structue under native conditions is a peculiar 440 
property of intrinsically disordered proteins (IDP).[43,44] In this framework, IDPs might 441 
represent a specific signal vehiculated by mvG and the lack of protein structural constraints 442 


















Fig. 3. MVs characterization by infrared spectroscopy. Microvesicles produced by glial cells via bzATP or s-GO 445 
stimulation and characterized by infrared spectroscopy. a) Infrared spectra of microvesicles obtained by bzATP 446 
stimulation (mvA, in orange) or by s-GO exposure (mvG, in black) in the region 950-3600 cm-1. Contributions 447 
arisen from nucleic acids, proteins and lipids characterize the spectra. The two boxes in green and the green dashed 448 
lines are used as eye-guides to highlight nucleic ac ds, CH2-CH3 stretching of lipids and protein amide bands, 449 
respectively. b) Fitting procedure applied to mvA (on the left) and mvG (on the right) amide bands spectra. 450 
Multicomponent Gaussian curves were used to actually reproduce the experimental data. The centres of the 451 
Gaussian curves were chosen as the minimum of the 2nd derivative of the spectrum and kept free to variate within 4 452 
cm-1 around its maximum. c) Histograms representing the areas of the Gaussian curves used to reproduce the 453 
experimental data of mvA (in orange) and mvG (in black) in the region 1500-1785 cm-1. The areas of each band has 454 
been weighted respect to the total amide band area which they belongs to (i.e. 1640 cm-1 band has been weighted 455 
with respect to the total Am-I band area).    456 
It is clearly visible that mvA and mvG vesicles have a different secondary structure: the former is mainly 457 
characterized by an intense peak at 1645 cm-1 (43%), which can be assigned to random structures/a-helix structure, 458 
and at 1678 cm-1 (22%) usually assigned to b-turn and at 1613 cm-1 (27%), which could be assigned to side chains 459 
vibrations; in contrast, mvG are mainly characterized by anti-parallel b-sheets structure (1632 (15%) and 1693 cm-1 460 
(3%) bands) with a strong contribution of flexible 3-10 helix (1661 cm-1 peak (34%)) and of side chain band at 1610 461 
cm-1 (37%).  462 
 463 
Finally, we set up a functional test to compare the impact of mvG delivery with that of mvA on 464 
synaptic activity, when neuronal networks are acutely and transiently exposed to MVs. To this 465 
aim, we isolated cortical neurons and glial cells from postnatal rat cortices and cultured them for 466 
10 days. Fig. 4a shows confocal high magnification microscopy images of cortical cultures 467 
where neurons were visualized by labeling class III β-tubulin (in red), a microtubule component 468 
expressed exclusively by neurons, while astrocytes w re visualized by GFAP labeling (in 469 
green).[45] We patch-clamped visually identified cortical neurons (in voltage clamp 470 
configuration, holding potential – 70 mV), while a second pipette for the local delivery of saline 471 
solution was positioned at a distance of 200 μm (under microscopy visual control) from the 472 
recorded cell (sketched in Fig. 4a, right). We estima ed that, at this distance, the application of a 473 








transient delivery of standard saline solution alone r containing mvG or mvA (re-suspended in 475 
saline). A typical feature of these cultures is the prominent expression of spontaneous synaptic 476 
activity, represented by heterogeneous postsynaptic currents (PSCs) of variable frequency and 477 
amplitude (box plots in Fig. 4b). Baseline PSCs were recorded before (10 min) and after (15 478 
min) the local saline, mvG or mvA ejection. Fig. 4c shows representative current tracings where 479 
standard saline was pressure ejected (light grey, top) or where mvA solution (orange, middle) 480 
and mvG (black, bottom) were administered.  481 
Since spontaneous fluctuations in PSCs frequency ≤ 15 % of baseline values were frequently 482 
detected, we took this as the threshold value to estimate changes when comparing PSCs before 483 
and after pressure ejections of saline. In the large majority (88 %, n = 16/18 neurons; histograms 484 
in Fig. 4d) of neurons exposed to saline solution alone, spontaneous PSCs frequency did not 485 
change. On the contrary, within 5-8 min from the acute mvA and mvG ejections, PSCs frequency 486 
was stably increased in 64 % (n= 16/25 neurons, mvA) and 54 % (n= 13/24 neurons, mvG; 487 
summarized in the histograms of Fig. 4d) of recorded n urons. Fig. 4e shows the increases in 488 
PSCs frequency in individual experiments and highlights the variability of such changes when 489 
administering MVs, with increased frequencies ranging from 25 % to 200 %. Since we could not 490 
experimentally control the amount of MVs collected by primary astrocytes and delivered by 491 
pressure ejection, neurons were exposed to different amounts of MVs and this can in part explain 492 
the detected variability. PSCs frequency increases due to MVs exposures were not reversible 493 
upon 20 min washout. From such functional investigation, glial-signaling generated by ATP or s-494 
GO affected similarly neuronal synapses upon transient, direct exposure.  495 
To our knowledge, this is the first time that the functional effects of MVs generated by 496 








Neuroglia extracellular vesicles have been described to provide support on synaptic activity, with 498 
the majority of studies focused on microglia and inflammation, apparently regulating neural 499 
transmission at the pre-synaptic level.[5,46–48] Astrocytic MVs have been proposed to exert 500 
neuroprotective effects in neuropathology and in physiology, however the role of astrocytes or of 501 
discrete astrocyte populations in delivering different messages via MV release has yet to be 502 
elucidated.[49,50] 503 
After assessment of the ability of MVs released by glial cells to affect cortical neuron 504 
physiology within min after their interaction with e targeted neuron, we asked if the presumed 505 
fusion of vesicles with neuronal plasma membrane could also affect their mechanical properties. 506 
To investigate this aspect, we delivered MVs obtained from glial cultures previously treated with 507 
bzATP or s-GO to cortical neurons by re-suspending the isolated MVs in 100 μL of neuronal 508 
culture medium and adding them to neuronal cultures. 24 hours after the exposure, force 509 
spectroscopy measurement on treated neuronal cultures were performed with AFM by 510 
positioning the tipless cantilever with a borosilicate glass bead previously glued on it[51], at the 511 
center of randomly chosen neurons. As showed by the boxplot in Fig. 4f, the exposure to mvA 512 
caused a significant softening of neuronal soma, when compared to controls (medianmvA = 0.22 513 
kPa, mediancontrol = 0.59 kPa; PmvA < 0.001). A similar result was observed also in the case of 514 
mvG exposure even if the effect exerted on neuronal stiffness is less pronounced than that 515 
induced by mvA (medianmvG = 0.28 kPa, mediancontrol = 0.59 kPa; PmvG < 0.01). The reported 516 
effect of mvA and mvG on neuronal cell mechanical properties is presumably a consequence of 517 
vesicular fusion with the cellular plasma membrane, which may affect its lipid composition. 518 
Since the mechanical properties of a cell are mostly defined by plasma membrane features and 519 









composition can partially justify the observed reduction in mvA and mvG-treated neurons 521 
stiffness.[52] In particular, glia-derived MVs are able to transport the enzyme Acid 522 
sphingomyelinase (A-SMase) involved in the metabolism of sphingomyelin (SM), a precursor of 523 
the phospholipid sphingosine (sph). Sph and its metabolites have been already reported to play a 524 
fundamental role in facilitating synaptic vesicles r lease by changing the membrane composition 525 
at pre-synaptic level.[48,53] This intrinsic capacity of MVs to participate in mebrane lipid 526 
metabolism may therefore modulate the contribution of plasma membrane to neuronal rigidity. 527 
In this context, the slight difference of stiffness values reported among mvA and mvG-treated 528 
neurons, although not statistically significant (PmvA-mvG> 0.05) should not be 529 
underestimated.[54,55] It is tempting to speculate that this difference can be explained by the 530 
presence of specific proteins in the vesicles, thatare unstable in mvG. Based on our measures, 531 
we cannot exclude the presence of residual s-GO flakes either inside or on the vesicle surface. It 532 
is known that GO is reportedly able to interact with the hydrophobic region of biological and 533 
model lipid membranes, even though the nature of the interaction is strictly dependent to its size 534 
and degree of surface oxygenation.[56,57] Assuming that the GO nanosheets, once added to the 535 
culture medium, can adsorb on plasma membrane or pierce t and being embedded in the lipid 536 
bilayer, there is a concrete possibility that MVs, which directly originate from plasma membrane, 537 
can include those flakes in their structure.[30] The horizontal transfer of s-GO from glial cells to 538 
cortical neurons, mediated by MVs, may therefore aff ct plasma membrane rigidity of targeted 539 
neurons. Regardless of this, we can exclude a direct effect of s-GO in synaptic transmission, 540 
reported to be transient and reversible upon acute exposure, in view of the persistent modulation 541 


















Fig. 4. MVs released by astrocytes affect cortical neuron post-synaptic activity and mechanical properties. 544 
Potentiation of synaptic activity upon local applicat ons of MVs in cortical neurons. a) Confocal micrograph 545 
visualizing cortical primary cultures at 8 days in v tro; anti-class III β-tubulin is used to visualize neurons (in red), 546 
anti-GFAP for astrocytes (in green) and DAPI (in blue) to visualize neurons. Scale bar 50 μm.  On the right, a 547 
representation of the experimental setting for the simultaneous MVs pressure-release (puff) and the cell patch-clamp 548 
recording from cultured neurons. b) Box plot summarizes the PSCs frequency and amplitude values in control 549 
cortical neurons. c) Top: diagram of the experimental protocol. Bottom: representative current tracings of the 550 
spontaneous synaptic activity detected prior and after puff applications of control saline (in light grey) or mvA (in 551 
orange) or mvG (in black). d) Bar plots of pooled data summarize the % of cells displaying PSCs frequency increase 552 
upon delivery of pressure ejected saline (light grey), mvA (orange) and mvG (black). Note that in contr l (saline) 553 
the large majority (88 %) of neurons did not increase their basal activity. e) The plot summarizes the distribution of 554 
the % of increase in PCSs frequency detected within the three groups. f) Elastic moduli of cortical neurons, grown 555 
on glass, and exposed to MVs isolated from glial cells previously treated with bzATP (orange) or s-GO flakes 556 
(black). Neurons treated with mvA and mvG are signif cantly less rigid if compared with control (PmvA < 0.001; 557 
PmvG <0.01). Thick horizontal bars in the box plots indicate median value; boxed area extends from the 25
th to 75th 558 
percentiles, whiskers from 5th to the 95th percentiles. Significance: **P < 0.01 ***P < 0.001, Kruskal-Wallis test, 559 
Dunn’s post hoc test) g. Indentation curves of cortical neurons previously treated with mvA or mvG. 560 
 561 
4. Conclusion 562 
Astrocyte-derived MVs may play significant roles in propagating signaling molecules, in CNS 563 
physiology and disease. Despite the increasing knowledge on extracellular vesicles (in particular 564 
exosomes) ability to promote inflammation or contribute in spreading of pathogenic proteins in 565 
neurodegenerative disorders (from Amyotrophic Lateral Sclerosis to Alzheimer disease [58,59]) 566 
little is currently known on their properties (mechanical, biochemical, lipid membrane 567 
composition, cargo nature etc.), in particular when focusing on the smaller class of such natural 568 
vectors, the MVs. Nevertheless, MVs emerge as key players in neuronal and synaptic 569 
physiology, able to influence neurotransmission, or to support neurons.[48,60–62] In our study, 570 
we report the ability of artificially generating MVs by s-GO transient exposure. MVs generated 571 
by s-GO were apparently characterized by altered protein content when compared to the ATP-572 









supposedly being related to features diverse from MV protein content. The ability of s-GO to 574 
interfere with exo-endocytotic membrane dynamics is not surprising, indeed we have described 575 
the ability of s-GO nanoflakes to interfere with presynaptic vesicle release in vitro and in 576 
vivo.[19,20] In the current work, we describe the direct interference of MVs with synaptic 577 
activity, presumably due to MVs fusion with the target neuron plasma membrane. Such an 578 
approach holds the potential to open new opportunities in engineering MVs for synaptic 579 
targeting. In this framework, it is tempting to speculate that s-GO interactions with the cell 580 
membrane mimic extracellular mechanical signaling at the nanoscale sufficient to enable the 581 
release of MVs, thus representing unconventional tools to exploit the physics governing vesicle 582 
release. We feel pertinent here to consider the fact, that the enormous potentiality of graphene-583 
based materials in nanomedicine has already promoted th  development of new generation-584 
nanocarriers for either gene or drug delivery[17,63]. In this framework, we may speculate on 585 
future developments where engineered cells are mechanically induced to release MVs, carrying 586 
GO nanoflakes properly functionalized to deliver genes or drugs of interest and thus representing 587 
either the trigger and the cargo. 588 
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Graphene oxide interferes with cell membrane dynamics and enhance astrocytes’ release of MVs 
MVs driven by graphene oxide stimuli display a different protein profile from chemically driven ones 
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